186 related articles for article (PubMed ID: 7796931)
1. Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy.
Pedersen SB; Bjørn SF; Richelsen B; Flyvbjerg A
Mol Cell Endocrinol; 1995 Jan; 107(1):123-8. PubMed ID: 7796931
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of renal ornithine decarboxylase activity prevents kidney hypertrophy in experimental diabetes.
Pedersen SB; Flyvbjerg A; Richelsen B
Am J Physiol; 1993 Feb; 264(2 Pt 1):C453-6. PubMed ID: 8447376
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes.
Thomson SC; Deng A; Bao D; Satriano J; Blantz RC; Vallon V
J Clin Invest; 2001 Jan; 107(2):217-24. PubMed ID: 11160138
[TBL] [Abstract][Full Text] [Related]
4. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
[TBL] [Abstract][Full Text] [Related]
5. Increased ornithine decarboxylase activity in kidneys undergoing hypertrophy in experimental diabetes.
Pedersen SB; Flyvbjerg A; Grønbaek H; Richelsen B
Mol Cell Endocrinol; 1992 Jul; 86(1-2):67-72. PubMed ID: 1511780
[TBL] [Abstract][Full Text] [Related]
6. Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the rat.
Humphreys MH; Etheredge SB; Lin SY; Ribstein J; Marton LJ
Am J Physiol; 1988 Aug; 255(2 Pt 2):F270-7. PubMed ID: 3136663
[TBL] [Abstract][Full Text] [Related]
7. Implication of ornithine decarboxylase and polyamines in pancreatic growth of neonatal rats.
Morisset J; Grondin G
Pancreas; 1987; 2(3):303-11. PubMed ID: 3114741
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of ornithine decarboxylase in distal tubules of early diabetic rat kidneys: are polyamines paracrine hypertrophic factors?
Deng A; Munger KA; Valdivielso JM; Satriano J; Lortie M; Blantz RC; Thomson SC
Diabetes; 2003 May; 52(5):1235-9. PubMed ID: 12716758
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the role of polyamines in different models of kidney hypertrophy in mice.
Tovar A; Sánchez-Capelo A; Cremades A; Peñafiel R
Kidney Int; 1995 Sep; 48(3):731-7. PubMed ID: 7474658
[TBL] [Abstract][Full Text] [Related]
10. Effects of gestational or neonatal treatment with alpha-difluoromethylornithine on ornithine decarboxylase and polyamines in developing rat brain and on adult rat neurochemistry.
Sparapani M; Virgili M; Caprini M; Facchinetti F; Ciani E; Contestabile A
Exp Brain Res; 1996 Mar; 108(3):433-40. PubMed ID: 8801123
[TBL] [Abstract][Full Text] [Related]
11. Postnatal development of ornithine decarboxylase and polyamines in the mouse kidney: influence of testosterone.
Sánchez-Capelo A; Peñafiel R; Tovar A; Galindo JD; Cremades A
Biol Neonate; 1994; 66(2-3):119-27. PubMed ID: 7993945
[TBL] [Abstract][Full Text] [Related]
12. Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme.
Hsu HC; Thomas T; Seibold JR; Thomas TJ
Agents Actions; 1993; 39 Spec No():C204-6. PubMed ID: 8273569
[TBL] [Abstract][Full Text] [Related]
13. Polyamines and intestinal epithelial hyperplasia in streptozotocin-diabetic rats.
Younoszai MK; Parekh VV; Hoffman JL
Proc Soc Exp Biol Med; 1993 Feb; 202(2):206-11. PubMed ID: 8424111
[TBL] [Abstract][Full Text] [Related]
14. Role of ornithine decarboxylase and polyamines in early postnatal lung growth.
Thet LA; Parra SC
J Appl Physiol (1985); 1986 Nov; 61(5):1661-6. PubMed ID: 3096943
[TBL] [Abstract][Full Text] [Related]
15. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
[TBL] [Abstract][Full Text] [Related]
16. Ornithine decarboxylase and mucosal growth in response to feeding.
Tabata K; Johnson LR
Am J Physiol; 1986 Aug; 251(2 Pt 1):G270-4. PubMed ID: 3090896
[TBL] [Abstract][Full Text] [Related]
17. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J
J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of immediate-early-gene induction in renal mesangial cells by depletion of intracellular polyamines.
Schulze-Lohoff E; Fees H; Zanner S; Brand K; Sterzel RB
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):647-53. PubMed ID: 8141779
[TBL] [Abstract][Full Text] [Related]
19. Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt.
Miracle CM; Rieg T; Mansoury H; Vallon V; Thomson SC
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F995-F1002. PubMed ID: 18562630
[TBL] [Abstract][Full Text] [Related]
20. Polyamines and intestinal growth: absolute requirement for ODC activity in adaptation during lactation.
Yang P; Baylin SB; Luk GD
Am J Physiol; 1984 Nov; 247(5 Pt 1):G553-7. PubMed ID: 6437251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
